Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukine, Thalomid, and Taxotere in Hormone-Naïve Prostate Cancer With Rising PSA
NCT00450008Phase 2Terminated
- Sponsor
- Houston Methodist Research Institute
- Start
- Dec 2006
- Primary completion
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim, thalidomide, docetaxel in prostate cancer (PCa), sponsored by Houston Methodist Research Institute. Started Dec 2006; status: terminated.
02
Drugs
sargramostimthalidomidedocetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00450008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450008.